Izokibep not checked

ACELYRIN Inc. · ABY-035

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
8 in total · 3 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Biologic: IL-17A inhibitor Form: Solution for injection Route of administration: Subcutaneous (SC)”In the company’s words, NCT05623345 on ClinicalTrials.gov
Tested for
Hidradenitis Suppurativa (2 trials), Psoriatic Arthritis (2 trials), Uveitis (2 trials), Plaque Psoriasis, Ankylosing Spondylitis
Main trialPhase 3
“Izokibep is a small protein molecule that acts as a selective, potent inhibitor of interleukin 17A, to which it binds with high affinity. This study investigates izokibep in participants with active Hidradenitis Suppurativa (HS), including tumor necrosis factor-alpha inhibitor (TNFi) naïve participants, and those who had an inadequate response or intolerance to TNFi, or for whom TNFi is contraindicated.”In the company’s words, NCT05905783 on ClinicalTrials.gov
Other names
ABY-035

Other drugs for Hidradenitis Suppurativa

All 29 drugs for Hidradenitis Suppurativa

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials8

TrialPhaseCompletesWhat it tests
Phase 3Terminated 24 Jul 2024 Hidradenitis Suppurativa Study of Izokibep
Phase 2/3Terminated 30 Nov 2023 Psoriatic Arthritis Study of Izokibep
Phase 2Completed 27 Mar 2019 A Study to Evaluate ABY-035 in Subjects With Moderate-to-severe Plaque Psoriasis
Phase 2Completed 1 Oct 2021 A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic Arthritis
Phase 2Terminated 11 Jul 2022 ABY-035 in the Treatment of Subjects With Ankylosing Spondylitis
Phase 2Completed 25 Aug 2022 A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior Uveitis
Phase 2Completed 2 Aug 2023 Hidradenitis Suppurativa Phase 2b Study of Izokibep
Phase 2Terminated 7 Feb 2025 Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Izokibep

Following is part of Solo: you see every change to Izokibep the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in